The IPO of vaccine manufacturing firm GreenSignal Bio Pharma was subscribed 89 per cent on the fourth day of the bidding today.
The company has extended its initial public offer by three days to November 17.
The IPO received bids for 1,30,10,550 shares against the total issue size of 1,45,79,560 shares, data available with the NSE till 1700 hours showed.
The non-institutional investor category was subscribed 13 per cent while that of retail investor portion received 8.73 times bids.
The offer was earlier scheduled to close on Friday.
The company has entered the capital market with its IPO of 1,45,79,560 shares of face value of Rs 10 each through an offer for sale. It has fixed the price band at Rs 76-80.
The shares are proposed to be listed on BSE and NSE.
The firm is into manufacturing of BCG vaccine given for protection against tuberculosis, mainly severe forms of childhood tuberculosis.
GreenSignal Bio Pharma is the 25th company to hit the market with its IPO this year.
Disclaimer: No Business Standard Journalist was involved in creation of this content
